{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:48:26Z","timestamp":1783158506737,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.tmaid.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T02:30:45Z","timestamp":1494037845000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995\u20132014"],"prefix":"10.1016","volume":"17","author":[{"given":"Kathrine R.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rennie W.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Arguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2017.05.003_bib1","series-title":"CDC health information for international travel 2016","author":"Centers for Disease Control and Prevention","year":"2016"},{"issue":"18","key":"10.1016\/j.tmaid.2017.05.003_bib2","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.296.18.2234","article-title":"Prevention of malaria in long-term travelers","volume":"296","author":"Chen","year":"2006","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.tmaid.2017.05.003_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tmaid.2013.12.006","article-title":"Compliance with long-term malaria prophylaxis in British expatriates","volume":"12","author":"Cunningham","year":"2014","journal-title":"Travel Med Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2017.05.003_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4269\/ajtmh.15-0245","article-title":"Safety, tolerability, and compliance with long-term antimalarial chemoprophylaxis in American soldiers in Afghanistan","volume":"93","author":"Saunders","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.tmaid.2017.05.003_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tmaid.2014.12.001","article-title":"Adherence to malaria prophylaxis among peace corps volunteers in the Africa region, 2013","volume":"13","author":"Landman","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.05.003_bib6","article-title":"Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects","author":"Food and Drug Administration","year":"2013","journal-title":"U.\u00a0S FDA"},{"issue":"1","key":"10.1016\/j.tmaid.2017.05.003_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tmaid.2014.10.021","article-title":"Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports","volume":"13","author":"Ringqvist","year":"2015","journal-title":"Travel Med Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2017.05.003_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"American Academy of O. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.tmaid.2017.05.003_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res Hob"},{"issue":"4","key":"10.1016\/j.tmaid.2017.05.003_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","article-title":"Centers for Disease C, Prevention. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis","volume":"84","author":"Tan","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.tmaid.2017.05.003_bib11","first-page":"253","article-title":"The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan","volume":"51","author":"Sonmez","year":"2005","journal-title":"J\u00a0Infect"},{"issue":"7423","key":"10.1016\/j.tmaid.2017.05.003_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bmj.327.7423.1078","article-title":"Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study","volume":"327","author":"Schlagenhauf","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.tmaid.2017.05.003_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.amepre.2007.04.029","article-title":"Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers","volume":"33","author":"Korhonen","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.tmaid.2017.05.003_bib14","series-title":"Mefloquine hydrochloride","author":"Inc","year":"2011"},{"issue":"1","key":"10.1016\/j.tmaid.2017.05.003_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.16-0390","article-title":"Neuropsychiatric outcomes after mefloquine exposure among U.S. Military service members","volume":"96","author":"Eick-Cost","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.tmaid.2017.05.003_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tmaid.2015.03.010","article-title":"Mefloquine at the crossroads? Implications for malaria chemoprophylaxis in Europe","volume":"13","author":"Schlagenhauf","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.05.003_bib17","first-page":"1069","article-title":"Activity of a new antimalarial agent, chloroquine (SN 7618)","volume":"130","year":"1946","journal-title":"J\u00a0Am Med Assoc"},{"issue":"11","key":"10.1016\/j.tmaid.2017.05.003_bib18","first-page":"238","article-title":"Antimalarial effects of tetracyclines in man","volume":"74","author":"Clyde","year":"1971","journal-title":"J\u00a0Trop Med Hyg"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917300741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917300741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:28Z","timestamp":1761487348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893917300741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":18,"alternative-id":["S1477893917300741"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.05.003","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995\u20132014","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}